Retinitis Pigmentosa clinical trials at UCSD
2 in progress, 1 open to eligible people
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
open to all eligible people
The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
San Diego, California and other locations
OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis
Sorry, in progress, not accepting new patients
This is a Phase 1/2 Study to Assess the Safety and Efficacy of OCU400 in patients with retinitis pigmentosa associated with NR2E3 and RHO mutations and in patients with LCA due to mutation(s) in CEP290 gene (OCU400-101). To document prospective eye pathology in the above subjects Investigators will also conduct a Natural History Study (OCU400-104)i This is a multicenter study, which will be conducted in two phases and will enroll up to a total of 24 subjects in the OCU400-101 and 100 subjects in the OCU400-104 study.
La Jolla, California and other locations
Our lead scientists for Retinitis Pigmentosa research studies include Richard Haas, MD PhD Robert Naviaux, MD.
Last updated: